Cox, M Christina <br/><br/>
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.  [electronic resource] 

 -  Investigational new drugs  06 2019 
 - 548-558 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-019-00769-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--administration & dosage<br/>Drug Administration Schedule<br/>Etoposide--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Organic Chemicals--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Retrospective Studies<br/>Rituximab--administration & dosage<br/>Survival Rate<br/>Vincristine--administration & dosage